resource-symbol

Eustachian Tube Dysfunction Questionnaire (ETDQ-7)

McCoul Edward D.; Anand VK; Christos PJ

Distributed by Mapi Research Trust

Distributed by Mapi Research Trust

default distrib
 

Basic description

Published in 2012

Authors

McCoul Edward D.; Anand VK; Christos PJ

Copyright
Instrument controlled by Wiley
Objective
To clinically assess symptoms and treatment outcome in Eustachian tube dysfunction (ETD)
Therapeutic indication

Eustachian tube dysfunction

Type of Clinical Outcome Assessment (COA)
  • PRO PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

McCoul, E. D., Anand, V. K. and Christos, P. J. (2012), Validating the clinical assessment of eustachian tube dysfunction: The Eustachian Tube Dysfunction Questionnaire (ETDQ-7). The Laryngoscope, 122: 1137–1141 (Full text article)


Contact and conditions of use

Authors

McCoul Edward D.; Anand VK; Christos PJ

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Licensing for the original version

The use of the original version of the questionnaire is licensed by Wiley.

A license agreement must be completed beforehand and a user fee is required to all users (commercial and academic users).

Please contact: permissions@wiley.com

Distribution of Translations

Existing translations can be obtained from Mapi Research Trust:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the Request for Translations form, or any other document to your online request. Click the link below for the Request for Translations form
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Access fees

ROYALTY FEES* Commercial users Cost per study See above, under "Licensing for the original version"
Cost per language See above, under "Licensing for the original version"
Funded academic research Cost per study See above, under "Licensing for the original version"
Cost per language See above, under "Licensing for the original version"
Not funded academic users Cost per study See above, under "Licensing for the original version"
Cost per language See above, under "Licensing for the original version"
DISTRIBUTION FEES* Commercial users Cost per study Free
Cost per language 750 Euros
Funded academic research Cost per study Free
Cost per language 100 Euros
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Languages

Original language(s)

  • English for the USA

Translations

The translations listed may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

ETDQ-7

Spanish for the USA*
* Performed by Mapi

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi

More information on translations

To obtain existing translations of the ETDQ-7, please submit a request 

Note: A per-translation fee is requested

Last update: November 2017
For additional information, please submit a request. More information in our FAQs.